Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
gaviscon advance
- Development stage
- Phase 3
- Lead developer
- Reckitt Benckiser Healthcare
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Gaviscon Advance is a reflux suppressant medication for the relief of heartburn and acid indigestion (dyspepsia), including symptoms such as burning in the chest, bloating, sour taste in the mouth, and difficulty swallowing. It is suitable for use during pregnancy and breastfeeding. The product forms a protective layer that floats on top of stomach contents to prevent reflux into the esophagus. Its active ingredients are sodium alginate and potassium hydrogen carbonate (potassium bicarbonate). The mechanism of action involves both antacid effects to neutralize excess stomach acid and alginate raft formation to physically block reflux.
- Brand names
- Gaviscon Advance
- Other names
- Gaviscon Advance Oral SuspensionGaviscon Advance LiquidGaviscon Advance Peppermint SuspensionGaviscon Advance Aniseed Flavour
02
Targets
HCl (Hydrochloric acid)
Beyond the preview
Go deeper on gaviscon advance.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on gaviscon advance.